Skip to content
10-Q

Quarterly Report

AMEXDRUG CORP

0001096906-12-001428

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 14, 2012 8.47M sh
Stockholders Equity Q1 2012 · Mar 31, 2012 $451.72K
Stockholders Equity Q1 2012 · Dec 31, 2011 $348.58K
Current Liabilities Q1 2012 · Mar 31, 2012 $782.66K
Current Liabilities Q1 2012 · Dec 31, 2011 $1.25M
Current Assets Q1 2012 · Mar 31, 2012 $1.14M
Current Assets Q1 2012 · Dec 31, 2011 $1.5M
Total Assets Q1 2012 · Mar 31, 2012 $1.23M
Total Assets Q1 2012 · Dec 31, 2011 $1.6M
Stock Repurchased Q1 2012 · Mar 31, 2011 $607
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$120.09K
Sga Expense Q1 2012 · Mar 31, 2011 $150.63K
Net Income Q1 2012 · Mar 31, 2011 $164.11K
Operating Income Q1 2012 · Mar 31, 2011 $279.71K
Gross Profit Q1 2012 · Mar 31, 2011 $431.3K
Cost Of Revenue Q1 2012 · Mar 31, 2011 $2.41M
Revenue Q1 2012 · Mar 31, 2011 $2.84M